A new federal research grant will enable the Framingham Heart Study, the nation’s longest-running multigenerational study of cardiovascular disease, to explore the biology of aging.

In the next phase of the 71-year-old study, researchers from Boston University’s School of Medicine will measure changes in traits such as blood pressure, stiffness of arteries, stickiness of blood platelets, and fat accumulation in the liver of participants — most of them children or grandchildren of Framingham residents first enrolled in the study in 1948.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy